Search

  • Search

    MLPA-Based CNV Testing for BRCA1/BRCA2

    HUS-yhtymä

    MLPA-Based CNV Testing for BRCA1/BRCA2

    1. Competition notice published

      Oct 7, 4:38 AMOctober 7, 2026 4:38 AM

    2. Questions deadline

      Oct 23, 9:00 AMOctober 23, 2026 9:00 AM

    3. Tender submission deadline

      Nov 9, 10:00 AMNovember 9, 2026 10:00 AM

    4. Opening date

      Nov 9, 10:05 AMNovember 9, 2026 10:05 AM

    5. Contract start date

      Feb 1, 12:00 AMFebruary 1, 2027 12:00 AM

    6. Tender validity period

      Mar 9, 10:00 AMMarch 9, 2027 10:00 AM

    Brief

    Finland: Tenders/HUS-yhtymä/MLPA-Based CNV Testing for BRCA1/BRCA2
    Brief

    Laboratorie- og analyseutstyr

    HUS Group, the joint authority for Helsinki and Uusimaa, needs an MLPA (Multiplex Ligation-dependent Probe Amplification) assay for the detection of copy number variations (CNVs) in BRCA1 and BRCA2 genes, including all reagents, controls, consumables, software, licenses, and other components required for routine use and generation of reportable patient results. The contract period is 2 years, after which it continues indefinitely until terminated. The estimated annual consumption is approximately 1600 reportable patient samples, to be delivered to the HUSLAB Laboratory of Genetics in Helsinki-Uusimaa, Finland. The award criterion is the lowest total comparison price.

    About the bid

      HUSLAB Laboratory of Genetics at HUS (Helsinki University Hospital) Diagnostic Center is an SFS-EN ISO 15189:2022 accredited laboratory providing diagnostic and follow-up genetic testing services for patients within the Helsinki University Hospital area. The object of the procurement is an MLPA (Multiplex Ligation-dependent Probe Amplification) assay for the detection of copy number variations (CNVs) in BRCA1 and BRCA2 genes, including all reagents, controls, consumables, software, licences and other components required for routine use of the assay and generation of reportable patient results. The procurement also includes any software, licences, user rights, technical support and related services required for operation of the assay, data analysis and result reporting The contract period shall be two (2) years, after which the agreement shall continue for an indefinite period until terminated in accordance with the terms of the agreement. The estimated annual consumption is approximately 1600 reportable patient samples.   The estimate is non-binding and provided for information purposes only. The contracting entity does not commit to any specific purchase volumes or quantities. Actual purchases will be made based on the contracting entity's needs and may be higher or lower than estimated.Main features of the procedureThe procurement shall comply with the Act on Public Procurement and Concession Contracts (1397/2016, referred to as the Public Procurement Act). The procurement value exceeds the EU threshold value. The procedure shall be an open procedure as defined in section 32 of the Public Procurement Act. The procedure shall include the following phases: Contracting entity 1. Opens the tenders 2. Verifies the suitability of the tenderer 3. Checks that the tenders conform to the invitation to tender 4. Compares the tenders 5. Requests and checks certificates and reports on the suitability of the winning tenderer(s) 6. Makes a procurement decision and communicates it to all the tenderers 7. Concludes an agreement with the selected tenderer(s) LANGUAGE OF THE COMPETITIVE TENDERING PROCEDURE Tenders may be submitted in either Finnish or English. Product brochures, technical documentation and other supporting materials may also be provided in either Finnish or English. PARTIAL TENDERS Partial tenders will not be accepted. PARALLEL TENDERS Parallel tenders are not permitted. ALTERNATIVE TENDERS Alternative tenders will not be accepted.

      Contact name
      Investoinnit ja diagnostiikka -kategoria
      Contact phone
      +358 94711
      Contact email
      kilpailutus.diagnostiikka@hus.fi
      Address
      PL 441 (Uutistie 5, 01770 Vantaa), 00029 HUS

    Custom Assessment Criteria

    Start a free trial to ask your own questions about the tender and get AI-generated answers.

    Award Criteria

    • Description

      Lowest total comparison price

      Evaluation Method

      The total agreed price is a non-variable sum.

    Qualification requirements

      Found no qualification requirements in the contract notice.

    Previous Contract Winners

    Start a free trial to see who has won similar tenders for this buyer.

    See the full notice

    Contracting authority
    HUS-yhtymä
    Title
    MLPA-Based CNV Testing for BRCA1/BRCA2
    Type
    CompetitionPrequalification
    Main code
    33696500Laboratory reagents
    Supplemental codes
    33000000Medical equipments, pharmaceuticals and personal care products
    Location
    Helsinki-Uusimaa
    Duration
    24 months

    Active similar competitions

    • HUS-yhtymä

      Helse- og sosial tjenesteyting

      HUS Subcontracting genetic diagnostic tests

      HUS Group needs genetic diagnostic test services to support clinical patient work and individual patient treatment decisions. These services are for various clinics within the HUS Joint Municipal Authority for Specialised Health Care, and also for ISLAB (Eastern Finland Laboratory Centre, Joint Authority Enterprise). The services are procured through a dynamic purchasing system. Suppliers must have a yearly turnover of at least EUR 500,000, a risk category of RL1-RL3, professional experience with similar genetic diagnostic test services for reference customers during the last three years, and the laboratory must have accreditation status secured for at least two years. Additionally, candidates must have experience in supplying at least 5000 genetic studies yearly for university-level or similar hospitals within the EU/EEA area. Award criteria for specific competitions will be based on overall financial affordability, which may include price and/or quality.

      Dynamic purchasing systemMar 24, 2025
      May 9, 2030(100+ days)

    • HUS-yhtymä

      Engroshandel med medisinske og husholdningsvarer

      Laboratorion muovitarvikkeet

      HUS-yhtymä perustaa dynaamisen hankintajärjestelmän (jäljempänä DPS) Laboratorion muovitarvikkeiden hankkimiseen. Hankittavat tuotteet määritellään tarkemmin kussakin dynaamisen hankintajärjestelmän sisäisessä kilpailutuksessa. Laboratorion muovitarvikkeiden DPS dynaaminen hankintajärjestelmä on voimassa 28.2.2027 saakka, ellei sitä erillisellä ilmoituksella lyhennetä tai pidennetä. HUS arvioi osallistumispyynnön julkaisuhetkellä, että dynaamisen hankintajärjestelmän sisällä julkaistaan vuosien 2023-2027 aikana 17 kilpailutusta. Määrä on alustava arvio, joka voi muuttua merkittävästikin kun kilpailutustarve ja tuotteiden ryhmittely selkeytyy myöhemmin. HUS arvioi osallistumispyynnön julkaisuhetkellä dynaamisen hankintajärjestelmän koko keston kokonaisarvoksi enintään 2 500 000 euroa huomioiden kaikki järjestelmässä mahdollisesti tehdyt hankinnat. Arvio on alustava ja perustuu tällä hetkellä tiedossa olevaan hankintatarpeeseen. HUS ei sitoudu mihinkään hankintamääriin tai määräostovelvoitteisiin tällä ilmoituksella.

      Dynamic purchasing systemMar 1, 2023
      Mar 1, 2027(100+ days)
      €2,500,000

    • HUS-yhtymä

      Laboratorie-kits og reagenser

      Automaattinen nukleiinihappojen eristyslaite

      HUS-yhtymä suunnittelee automaattisen nukleiinihappojen eristyslaitteen hankintaa HUS Diagnostiikkakeskuksen Kliinisen mikrobiologian nukleiinihappoanalytiikkaan, sisältäen laitteen, varalaitteen tai kaksi erillistä eristysmoduulia sekä tarvittavat reagenssit ja tarvikkeet. Hankittavalla laitteella on tarkoitus eristää bakteeri-DNA:ta useista eri näytemateriaaleista, ja eristetyn tuotteen tulee olla validoitu bakteerien 16S-geenin PCR-monistamiseen Sanger-sekvensoinnilla. Toimittajia pyydetään tutustumaan liitteenä oleviin kysymyksiin ja toimittamaan vastaukset sähköpostitse osoitteeseen kilpailutus.diagnostiikka@hus.fi. bioMérieux Suomi OY:llä on todennäköisesti sopimus tällä hetkellä.

      PlanningSep 16, 2026
      Jan 16, 2027(99 days)

    • HUS-yhtymä

      Medisinsk og laboratorieutstyr

      REQUEST FOR INFORMATION: SPRI Beads

      HUS-yhtymä is planning the procurement of DNA size selection reagents based on paramagnetic beads, utilizing SPRI technology for selective binding and purification of DNA fragments, to be used in next-generation sequencing (NGS) library preparation. Suppliers can provide feedback and input by submitting a response via email to kilpailutus.diagnostiikka@hus.fi, addressing all requirements, providing requested information and documentation, and identifying any concerns or proposed amendments to the draft agreement.

      PlanningAug 18, 2026
      Nov 1, 2026(23 days)

    • HUS-yhtymä

      Programvareprodukter og lisenser

      Family Pedigree Software Solution

      HUS-yhtymä needs a family pedigree software solution for the Clinical Genetics Unit, to be installed and operated within HUS-managed infrastructure. The procurement includes software licenses, implementation services, and related maintenance and support services. The software will be used by approximately 20 to 30 users, mainly physicians and nurses, within the Clinical Genetics Unit, and a small number of users from cardiology. The software is critical for daily operations, recording information for almost all patients and families, with approximately 150 to 200 patient visits per week. Reliable data preservation, availability, and retrievability are key requirements due to the long-term clinical significance of the stored information. Laboratory system integration may be procured as an optional service. The award criterion is the total price of all products.

      CompetitionSep 21, 2026
      Oct 22, 2026(13 days)